| Expression pattern: |
DN |
| Associated gene: |
CSE1L |
| Associated microRNA: |
has-miR-9, hsa-miR-125a/b, hsa-miR-153, has-miR-192, has-miR-371b, has-miR-1275, has-miR-4695 |
| Biological function: |
Potential ALS biomarker; may act as a miRNA sponge. |
| Molecular mechanism: |
Putative miRNA-sponging (ceRNA-like) mechanism based on predicted binding sites in circBank; reduced expression in ALS PBMCs. |
| Biological pathway or process: |
ceRNA regulation (other) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RNase R Treatment; RT-qPCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis |
| Clinical significance: |
Reduced in ALS PBMCs and shows diagnostic potential by ROC analysis (AUC ~0.75). |
| Description: |
hsa_circ_0060762 is significantly down-regulated in PBMCs from ALS patients versus controls and shows diagnostic potential (ROC AUC ~0.75). The study suggests it may have miRNA-binding capacity (miRNA-sponge-like role) based on circBank predictions, supporting its candidacy as a peripheral blood biomarker for ALS. |
| Confidence score: |
0.5963 |